At the news
? NEUTRALIMPACT 9/10 25-NSE filed Apr 23, 2026 at 09:14 ET
Nasdaq has filed Form 25 to delist Day One Biopharmaceuticals (DAWN) common stock, effective immediately, following the company's acquisition by Servier Pharmaceuticals. This is a procedural step confirming the completion of the take-private transaction.
- Form 25-NSE filed by Nasdaq to delist DAWN common stock
- Effective date of delisting is 2026-04-23
- Follows the previously announced acquisition of Day One by Servier Pharmaceuticals
- Merger closed after Servier secured 85.34% of shares via tender offer
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access